摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲基-2-氧代-2,3-二氢-1,3-苯并唑-6-磺酰氯 | 62522-63-8

中文名称
3-甲基-2-氧代-2,3-二氢-1,3-苯并唑-6-磺酰氯
中文别名
3-甲基-2-氧代-2,3-二氢-1,3-苯并恶唑-6-磺酰氯
英文名称
3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazole-6-sulfonyl chloride
英文别名
3-methylbenzoxazolinon-6-ylsulfonyl chloride;3-methylbenzoxazolone-6-sulfonyl chloride;3-Methyl-6-chlorsulfonyl-benzoxazolon;6-chlorosulfonyl-3-methylbenzoxazolin-2-one;3-methyl-2-oxo-2,3-dihydro-benzooxazole-6-sulfonyl chloride;3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonyl chloride;3-methyl-2-oxo-1,3-benzoxazole-6-sulfonyl chloride
3-甲基-2-氧代-2,3-二氢-1,3-苯并唑-6-磺酰氯化学式
CAS
62522-63-8
化学式
C8H6ClNO4S
mdl
MFCD03033702
分子量
247.659
InChiKey
MRSCMVKREGBNOW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    137-139℃
  • 沸点:
    388.2±44.0 °C(Predicted)
  • 密度:
    1.610±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    72.1
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • WGK Germany:
    3
  • 危险类别码:
    R14,R22,R29,R34
  • 海关编码:
    2934999090
  • 包装等级:
    III
  • 危险类别:
    8
  • 危险性防范说明:
    P280,P305+P351+P338,P310
  • 危险品运输编号:
    3261
  • 危险性描述:
    H302,H312,H314,H332
  • 储存条件:
    2-8°C

SDS

SDS:feb373c3d1157f9bb0af100fcd92f93f
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonyl chloride
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonyl chloride
CAS number: 62522-63-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6ClNO4S
Molecular weight: 247.7

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    3-甲基-2-氧代-2,3-二氢-1,3-苯并唑-6-磺酰氯 作用下, 以 甲醇 为溶剂, 反应 1.5h, 以17%的产率得到3-甲基-2-氧代-1,3-苯并恶唑-6-磺酰胺
    参考文献:
    名称:
    N-酰基磺酰胺类FBPase抑制剂、其制备方法、 药物组合物及用途
    摘要:
    本发明公开了新结构的N‑酰基磺酰胺类FBPase抑制剂、及其制法和药物组合物与用途。具体而言,本发明涉及通式I所示的N‑酰基磺酰胺类FBPase抑制剂,其可药用盐,及其制备方法,含有一个或多个该类化合物的组合物,和该类化合物在制备FBPase抑制剂或治疗FBPase有关的疾病药物中的用途,及在制备预防和/或治疗糖尿病药物中的用途。
    公开号:
    CN107098846B
  • 作为产物:
    描述:
    2-苯并唑啉酮氯磺酸 、 sodium hydride 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 10.0h, 生成 3-甲基-2-氧代-2,3-二氢-1,3-苯并唑-6-磺酰氯
    参考文献:
    名称:
    N-酰基磺酰胺类FBPase抑制剂、其制备方法、 药物组合物及用途
    摘要:
    本发明公开了新结构的N‑酰基磺酰胺类FBPase抑制剂、及其制法和药物组合物与用途。具体而言,本发明涉及通式I所示的N‑酰基磺酰胺类FBPase抑制剂,其可药用盐,及其制备方法,含有一个或多个该类化合物的组合物,和该类化合物在制备FBPase抑制剂或治疗FBPase有关的疾病药物中的用途,及在制备预防和/或治疗糖尿病药物中的用途。
    公开号:
    CN107098846B
点击查看最新优质反应信息

文献信息

  • ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
    申请人:Conticello Richard
    公开号:US20100016297A1
    公开(公告)日:2010-01-21
    The present disclosure provides compounds having affinity for the 5-HT 6 receptor which are of the formula (I): wherein R 1 , R 2 , Ar, m and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    本公开提供了具有对5-HT 6 受体亲和力的化合物,其化学式为(I): 其中R1、R2、Ar、m和n如本文所定义。本公开还涉及制备这种化合物的方法、含有这种化合物的组合物以及使用它们的方法。
  • [EN] CONDENSED HETEROCYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES CONDENSÉS AYANT UNE AFFINITÉ POUR LE RÉCEPTEUR 5-HT6
    申请人:MEMORY PHARM CORP
    公开号:WO2010021797A1
    公开(公告)日:2010-02-25
    The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I) wherein R1, A, B, D, E, G, Q, Ar, n, m, and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    本公开提供了具有亲和力的化合物,其对5-HT6受体具有亲和力,其化学式为(I),其中R1、A、B、D、E、G、Q、Ar、n、m和p如本文所定义。该公开还涉及制备这种化合物的方法、含有这种化合物的组合物以及使用方法。
  • ACYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
    申请人:Conticello Richard
    公开号:US20100029629A1
    公开(公告)日:2010-02-04
    The present disclosure provides compounds having affinity for the 5-HT 6 receptor which are of the formula (I): wherein R 1 , R 2 , R 5 , Q, G, Ar, m, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    本公开提供了具有对5-HT 6 受体亲和力的化合物,其化学式为(I): 其中R1、R2、R5、Q、G、Ar、m和n如本文所定义。本公开还涉及制备这种化合物的方法、含有这种化合物的组合物以及使用这些化合物的方法。
  • [EN] 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY<br/>[FR] COMPOSÉS 4'-AMINO CYCLIQUES PRÉSENTANT UNE AFFINITÉ POUR LE RÉCEPTEUR 5-HT6
    申请人:MEMORY PHARM CORP
    公开号:WO2010024980A1
    公开(公告)日:2010-03-04
    The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): formula (I) wherein Cy is selected from formula (Il) and wherein R1, R2, R3, Q, G, Ar, m, n and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    本公开提供了具有对5-HT6受体亲和力的化合物,其化学式为(I):化学式(I),其中Cy从化学式(II)中选择,R1、R2、R3、Q、G、Ar、m、n和p的定义如本文所述。该公开还涉及制备这种化合物的方法、含有这种化合物的组合物以及它们的使用方法。
  • PYRROLIDINE-SUBSTITUTED AZAINDOLE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
    申请人:Danca Mihaela Diana
    公开号:US20100022581A1
    公开(公告)日:2010-01-28
    The present disclosure provides compounds having affinity for the 5-HT 6 receptor which are of the formula (I): wherein R 1 , R 2 , A, B, D, E, G, Ar, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    本公开提供了具有亲和力的化合物,其对5-HT 6 受体具有亲和力,其化学式为(I): 其中R1、R2、A、B、D、E、G、Ar和n如本文所定义。本公开还涉及制备这种化合物的方法、含有这种化合物的组合物以及使用它们的方法。
查看更多

同类化合物

(N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) 钙离子载体A23187半镁盐 荧光增白剂EBF 苯并恶唑胺 苯并恶唑的取代物 苯并恶唑甲磺酰氯 苯并恶唑基-2-甲酰基-S-乙基-异缩氨基硫脲 苯并恶唑-2-羧酸酰肼 苯并恶唑-2-磺酸 苯并恶唑-2-甲酸 苯并恶唑-2-甲磺酸钠 苯并恶唑-2-乙酸 苯并恶唑 苯并噁唑-5-甲酸 苯并噁唑-2-羧酸乙酯 苯并噁唑-2-甲醛 苯并噁唑,4,7-二氯-2-(氯甲基)- 苯并噁唑,2-叠氮- 苯并噁唑,2-(氯甲基)-4,7-二氟- 苯并[d]恶唑-7-甲酸甲酯 苯并[d]恶唑-5-硼酸频哪醇酯 苯并[d]噁唑-6-甲醛 苯并[d]噁唑-2-羧酸甲酯 苯并[d]噁唑-2-甲醇 苯并[D]恶唑-7-胺 苯并[D]噁唑-4-基氨基甲酸叔丁酯 苯并[D]噁唑-2-羧酸钾 苯并-13C6-噁唑 离子载体 碘化二氢2-[3-(5,6-二氯-1,3-二乙基-1,3--2H-苯并咪唑-2-亚基)丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 硫代偏糖醛 甲酰胺,N-乙基-N-[6-[(3-甲酰基苯氧基)甲基]-2-苯并噁唑基]- 甲酰胺,N-[6-(溴甲基)-2-苯并噁唑基]-N-乙基- 甲基硫酸1-甲基-8-[(甲基氨基甲酰)氧代]喹啉正离子 甲基6-氨基-1,3-苯并恶唑-2-羧酸酯 甲基2-氨基-1,3-苯并恶唑-5-羧酸酯 甲基1,3-苯并恶唑-2-基乙酸酯 甲基-2-乙基-1,3-苯并唑-5-羧酸乙酯 甲基-1,3-苯并唑-5-羧酸乙酯 环戊二烯并[e][1,3]恶嗪-5,6-二胺 环戊二烯并[d][1,3]恶嗪-6,7-二胺 溴氯唑酮 溴化二氢2-[3-[1-[4-[(乙酰氨基)磺基基]丁基]-5,6-二氯-3-乙基-1,3--2H-苯并咪唑-2-亚基]丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 氰基二硫代亚氨酸(6-氯-2-氧代-3(2H)-苯并恶唑基)甲基甲基酯 氰基-二硫代亚氨酸甲基(2-氧代-3(2H)-苯并恶唑基)甲基酯 氯唑沙宗-2-13C-3-15N-羟基-18O 氯唑沙宗 氯化3-乙基-2-[2-(1-乙基-2,5-二甲基-1H-吡咯-3-基)乙烯基]苯并恶唑翁盐 昂唑司特 拂来星-d2